Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

286 IMATINIB
Erythema
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
(2005): Sugito M+, Rinsho Ketsueki 46(11), 1226
(2003): Duncan E+, Br J Haematol 122(1), 1
(2003): Pasmatzi E+, Acta Derm Venereol 83(5), 391
Erythroderma
(2006): Oztas P+, Acta Derm Venereol 86(2), 174
Exanthems
(2006): Nelson RP Jr+, Ann Allergy Asthma Immunol 97(2), 216
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
(2004): Park MA+, Allergy Asthma Proc 25(5), 345
(2003): Dogra S+, Natl Med J India 16(5), 285
(2002): Dagher R+, Clin Cancer Res 8(10), 3034
Exfoliative dermatitis
(2006): Nelson RP Jr+, Ann Allergy Asthma Immunol 97(2), 216
(2003): Tanvetyanon T+, Ann Pharmacother 37(12), 1818
Hypomelanosis
(2006): Brazzelli V+, Pediatr Dermatol 23(2), 175
(2005): McPartlin S+, Br J Haematol 129(4), 448
(2004): Grossman WJ+, J Pediatr Hematol Oncol 26(3), 214
(2003): Tsao AS+, Cancer 98(11), 2483
Lichen planus
(2004): Roux C+, Ann Dermatol Venereol 131(6-7 Pt I), 571
Lichenoid eruption
(2007): Chan CY+, Dermatol Online J 13(2), 29
(2006): Dalmau J+, Br J Dermatol 154(6), 1213
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
(2005): Prabhash K+, Indian J Derm, Venereol Leprol 71(4), 287
Mycosis fungoides
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
Necrolysis
(2003): Schaich M+, Ann Hematol 82(5), 303
Neutrophilic eccrine hidradenitis
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
(2005): Dib EG+, Leuk Res 29(2), 233
Palmar–plantar hyperkeratosis
(2006): Deguchi N+, Br J Dermatol 154(6), 1216
Peripheral edema
Petechiae (1–10%)
Photosensitivity
(2003): Rousselot P+, Br J Haematol 120(6), 1091
Pigmentation
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
(2004): Arora B+, Ann Oncol 15(2), 358
Pityriasis rosea
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
(2005): Brazzelli V+, JAmAcadDermatol53(5 Suppl 1), S240
(2003): Pasmatzi E+, Acta Derm Venereol 83(5), 391
(2002): Konstantopoulos K+, Dermatology 205(2), 172
Pruritus (6–10%)
(2003): Valeyrie L+, JAmAcadDermatol48(2), 201 (22 cases)
Psoriasis
(2005): Shimizu K+, Rinsho Ketsueki 46(10), 1152
Rash (sic) (32–39%)
(2005): Breccia M+, Eur J Haematol 74(2), 121
(2005): Modi S+, Breast Cancer Res Treat 90(2), 157 (25%)
(2005): Severino G+, Ann Pharmacother 39(1), 162
(2004): Curran MP+, BioDrugs 18(3), 207
(2003): Valeyrie L+, JAmAcadDermatol48(2), 201 (36 cases)
(2003): Verweij J+, Eur J Cancer 39(14), 2006 (69%)
(2001): van Oosterom+, Lancet 358(9291), 1421
Squamous cell carcinoma
(2003): Baskaynak G+, Eur J Haematol 70(4), 231
Stevens–Johnson syndrome
(2006): Nelson RP Jr+, Ann Allergy Asthma Immunol 97(2), 216
(2006): Scheinfeld N, JDrugsDermatol5(3), 228
(2005): Pavithran K+, Indian J Dermatol Venereol Leprol
71(4), 288
(2005): Severino G+, Ann Pharmacother 39(1), 162 (with
lansoprazole)
(2002): Hsiao LT+, Br J Haematol 117(3), 620
(2002): Vidal D+, Br J Haematol 119(1), 274
Toxic epidermal necrolysis
(2006): Scheinfeld N, J Drugs Dermatol 5(3), 228
Toxicity (sic)
(2003): Ugurel S+, Br J Cancer 88(8), 1157
Urticaria
(2006): Nelson RP Jr+, Ann Allergy Asthma Immunol 97(2), 216
Vasculitis
(2006): Scheinfeld N, J Drugs Dermatol 5(3), 228
Mucosal
Oral lichenoid eruption
(2004): Ena P+, J Dermatol Treatment 15(4), 253
(2002): Lim DS+, Dermatology 205(2), 169
Hair
Hair – follicular mucinosis
(2006): Scheinfeld N, J Drugs Dermatol 5(3), 228
(2004): Yanagi T+, Br J Dermatol 151(6), 1276
Nails
Nails – dystrophy
(2006): Deguchi N+, Br J Dermatol 154(6), 1216
Nails – pigmentation
(2006): Prabhash K+, Indian J Dermatol Venereol Leprol 72(1), 63
Eyes
Epiphora
(2003): Fraunfelder FW+, JOculPharmacolTher19(4), 371
(18%)
Eyelid edema
(2004): Maalouf T+, JFrOphtalmol27(1), 107
Macular edema
(2005): Masood I+, J Cataract Refract Surg 31(12), 2427
Periorbital edema
(2006): Scheinfeld N, J Drugs Dermatol 5(3), 228
(2003): Fraunfelder FW+, JOculPharmacolTher19(4), 371
(70%)
(2003): Ramar K+, J Clin Oncol 21(1), 172
(2003): Verweij J+, Eur J Cancer 39(14), 2006 (84%)
(2002): Esmaeli B+, Cancer 95(4), 881
Other
DRESS syndrome
(2006): Le Nouail P+, Ann Dermatol Venereol 133(8-9 Pt 1), 686
Gynecomastia (male)
(2003): Gambacorti-Passerini C+, Lancet 361(9373), 1954
Hepatotoxicity
(2006): Cross TJ+, Am J Hematol 81(3), 189
(2006): Ikeda K+, Leuk Lymphoma 47(1), 155
Myalgia/Myositis/Myopathy/Myotoxicity
(2004): Curran MP+, BioDrugs 18(3), 207
(2003): Prescrire Int 12(64), 49
(2002): Dagher R+, Clin Cancer Res 8(10), 3034
(2002): Tefferi A+, Blood 99(10), 3854
Panniculitis
(2003): Ugurel S+, Br J Dermatol 149, 678
Porphyria cutanea tarda
(2004): Breccia M+, Leukemia 18(1), 182
(2003): Ho AY+, Br J Haematol 121(2), 375
Pseudolymphoma
(2006): Scheinfeld N, J Drugs Dermatol 5(3), 228